Sanofi (SNY)

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.

The chart shows the growth of an initial investment of $10,000 in Sanofi, comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.

Sanofi (SNY) has returned -0.58% so far this year and -9.28% over the past 12 months. Over the last ten years, SNY has returned 5.96% per year, falling short of the S&P 500 Index benchmark, which averaged 12.16% annually.

Based on dividend-adjusted daily data since Jul 1, 2002, SNY's average daily return is +0.04%, while the average monthly return is +0.65%. At this rate, your investment would double in approximately 8.9 years.

Historically, 56% of months were positive and 44% were negative. The best month was Apr 2003 with a return of +17.5%, while the worst month was Oct 2014 at -18.1%. The longest winning streak lasted 8 consecutive months, and the longest losing streak was 4 months.

On a daily basis, SNY closed higher 51% of trading days. The best single day was Oct 28, 2008 with a return of +15.5%, while the worst single day was Oct 27, 2023 at -19.1%.

Sanofi has an annualized alpha of 1.70%, beta of 0.76, and R² of 0.29 versus S&P 500 Index. Calculated based on daily prices since July 02, 2002.

• This stock participated in 83.99% of S&P 500 Index downside but only 73.51% of its upside — more exposed to losses than it benefited from rallies.
• R² of 0.29 means this stock moves largely independently of S&P 500 Index — capture ratios reflect limited market correlation rather than active downside protection. Consider using a more representative benchmark.

SNY ranks 23 for risk / return — below 23% of stocks on our site. The returns aren't fully compensating for the risk involved. This isn't necessarily a dealbreaker, but factor it into your decision — especially if you're risk-averse.

The table below present risk-adjusted performance metrics for Sanofi (SNY) and compare them to a chosen benchmark (S&P 500 Index).

Sanofi provided a 4.59% dividend yield over the last twelve months, with an annual payout of $2.21 per share. The company has been increasing its dividends for 2 consecutive years.

The table displays the monthly dividend distributions for Sanofi. The dividends shown in the table have been adjusted to account for any splits that may have occurred.

The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.

The table below displays the maximum drawdowns of the Sanofi. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the Sanofi was 46.46%, occurring on Mar 6, 2009. Recovery took 855 trading sessions.

The current Sanofi drawdown is 15.32%.

The chart below shows the rolling one-month volatility.

The chart below illustrates the trends in the financial health of Sanofi over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.

The Valuation section provides an overview of how Sanofi is priced in the market compared to other companies in the Drug Manufacturers - General industry. It includes key financial ratios that help investors assess whether the stock is undervalued or overvalued.